glycine has been researched along with Angina at Rest in 12 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Higher activated partial thromboplastin time levels during inogatran treatment are related to increased risk of death, myocardial infarction or refractory angina." | 5.09 | Activated partial thromboplastin time and clinical outcome after thrombin inhibition in unstable coronary artery disease. ( Grip, L; Linder, R; Oldgren, J; Siegbahn, A; Wallentin, L, 1999) |
| "In the current study, we investigated molecular markers of coagulation activity, ie, prothrombin fragment 1+2 (F1+2), thrombin-antithrombin (TAT) complex, soluble fibrin (SF), and D-dimer, and their relation to death, myocardial infarction, and refractory angina during and after anticoagulant treatment in unstable coronary artery disease." | 5.09 | Coagulation activity and clinical outcome in unstable coronary artery disease. ( Grip, L; Linder, R; Oldgren, J; Siegbahn, A; Wallentin, L, 2001) |
| "Patients (n = 1209) admitted with suspected unstable angina, or non-Q wave myocardial infarction, were randomly assigned to double-blind treatment with inogatran or heparin bolus doses." | 5.08 | A low molecular weight, selective thrombin inhibitor, inogatran, vs heparin, in unstable coronary artery disease in 1209 patients. A double-blind, randomized, dose-finding study. Thrombin inhibition in Myocardial Ischaemia (TRIM) study group. ( , 1997) |
| "Inogatran was tolerated well." | 2.68 | Thrombin inhibition with inogatran for unstable angina pectoris: evidence for reactivated ischaemia after cessation of short-term treatment. ( Andersen, K; Dellborg, M; Emanuelsson, H; Grip, L; Swedberg, K, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (66.67) | 18.2507 |
| 2000's | 4 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauersachs, RM | 1 |
| Andersen, K | 4 |
| Dellborg, M | 4 |
| Emanuelsson, H | 1 |
| Grip, L | 4 |
| Swedberg, K | 1 |
| Talley, JD | 1 |
| Holmvang, L | 1 |
| Clemmensen, P | 1 |
| Wagner, G | 1 |
| Grande, P | 1 |
| Abrahamsson, P | 2 |
| Nørgaard, BL | 1 |
| Ravkilde, J | 1 |
| Thygesen, K | 1 |
| Linder, R | 3 |
| Oldgren, J | 3 |
| Egberg, N | 1 |
| Larson, G | 1 |
| Siegbahn, A | 3 |
| Wallentin, L | 3 |
| Lankes, W | 1 |
| Fleischer, K | 1 |
| Gulba, DC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Are Serial Electrocardiograms Additive to SeriAl Second-generations Troponins in Predicting Acute CoronAry Syndromes in PatienTs With Undifferentiated cHest Pain (ASAP CATH) Study[NCT01953276] | 382 participants (Anticipated) | Observational | 2013-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for glycine and Angina at Rest
| Article | Year |
|---|---|
[Low molecular weight heparin, fondaparinux and melagatran: new data and clinical studies].
Topics: Angina, Unstable; Animals; Anticoagulants; Azetidines; Benzylamines; Fondaparinux; Glycine; Heparin, | 2004 |
[Direct thrombin antagonists].
Topics: Acute Disease; Angina, Unstable; Angioplasty, Balloon, Coronary; Animals; Anticoagulants; Antithromb | 2001 |
Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data.
Topics: Angina, Unstable; Antithrombins; Arginine; Glycine; Heparin; Hirudin Therapy; Hirudins; Humans; Myoc | 2002 |
8 trials available for glycine and Angina at Rest
1 other study available for glycine and Angina at Rest
| Article | Year |
|---|---|
Low-molecular weight heparins.
Topics: Angina, Unstable; Animals; Anticoagulants; Antithrombins; Clinical Trials as Topic; Dalteparin; Enox | 1997 |